These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 21182542)

  • 1. Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy.
    El Awady MK; Anany MA; Esmat G; Zayed N; Tabll AA; Helmy A; El Zayady AR; Abdalla MS; Sharada HM; El Raziky M; El Akel W; Abdalla S; Bader El Din NG
    J Gastroenterol Hepatol; 2011 May; 26(5):843-50. PubMed ID: 21182542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of OAS1 gene polymorphism at exon 7 splice accepter site with interferon-based therapy of HCV infection in Pakistan.
    Imran M; Manzoor S; Khattak NM; Tariq M; Khalid M; Javed F; Bhatti S
    Viral Immunol; 2014 Apr; 27(3):105-11. PubMed ID: 24673406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of OAS1 Exon 7 rs10774671 Genetic Variation on Liver Fibrosis Progression in Egyptian HCV Genotype 4 Patients.
    Bader El Din NG; Anany MA; Dawood RM; Ibrahim MK; El-Shenawy R; El Abd YS; El Awady MK
    Viral Immunol; 2015 Nov; 28(9):509-16. PubMed ID: 26505957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL28B polymorphism as a predictor of antiviral response in chronic hepatitis C.
    Cieśla A; Bociąga-Jasik M; Sobczyk-Krupiarz I; Głowacki MK; Owczarek D; Cibor D; Sanak M; Mach T
    World J Gastroenterol; 2012 Sep; 18(35):4892-7. PubMed ID: 23002361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-density lipoprotein receptor genetic polymorphism in chronic hepatitis C virus Egyptian patients affects treatment response.
    Naga M; Amin M; Algendy D; Elbadry A; Fawzi M; Foda A; Esmat S; Sabry D; Rashed L; Gabal S; Kamal M
    World J Gastroenterol; 2015 Oct; 21(39):11141-51. PubMed ID: 26494968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-λ3 polymorphisms in pegylated-interferon-α plus ribavirin therapy for genotype-2 chronic hepatitis C.
    Ishiguro H; Abe H; Seki N; Sugita T; Aida Y; Itagaki M; Sutoh S; Shimada N; Furihata T; Tsubota A; Aizawa Y
    World J Gastroenterol; 2015 Apr; 21(13):3904-11. PubMed ID: 25852275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-λ-related genes and therapeutic response in Chinese hepatitis C patients.
    Zhang YY; Chen HB; Xu Y; Huang P; Wang J; Zhang Y; Yu RB; Su J
    World J Gastroenterol; 2015 Apr; 21(13):4006-13. PubMed ID: 25852288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-28B single nucleotide polymorphism of donors and recipients can predict viral response to pegylated interferon/ribavirin therapy in patients with recurrent hepatitis C after living donor liver transplantation.
    Kawaoka T; Takahashi S; Takaki S; Hiramatsu A; Waki K; Hiraga N; Miki D; Tsuge M; Imamura M; Kawakami Y; Aikata H; Ochi H; Onoe T; Tashiro H; Ohdan H; Chayama K
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1467-72. PubMed ID: 22432893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained virologic response and IL28B single-nucleotide polymorphisms in patients with chronic hepatitis C treated with pegylated interferon alfa and ribavirin.
    Jabłonowska E; Piekarska A; Koślińska-Berkan E; Omulecka A; Szymańska B; Wójcik K
    Acta Biochim Pol; 2012; 59(3):333-7. PubMed ID: 22924160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of
    Świątek-Kościelna B; Kałużna E; Strauss E; Nowak J; Bereszyńska I; Gowin E; Wysocki J; Rembowska J; Barcińska D; Mozer-Lisewska I; Januszkiewicz-Lewandowska D
    World J Gastroenterol; 2017 Jun; 23(21):3815-3824. PubMed ID: 28638221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting response to therapy in chronic hepatitis C: an approach combining interleukin-28B gene polymorphisms and clinical data.
    Ladero JM; Martin EG; Fernández C; Carballo M; Devesa MJ; Martínez C; Suárez A; Díaz-Rubio M; Agúndez JA
    J Gastroenterol Hepatol; 2012 Feb; 27(2):279-85. PubMed ID: 21722179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of IL28B and
    Domagalski K; Pawłowska M; Zaleśna A; Pilarczyk M; Rajewski P; Halota W; Tretyn A
    World J Gastroenterol; 2016 Nov; 22(41):9186-9195. PubMed ID: 27895405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism of OAS-1 determines liver fibrosis progression in hepatitis C by reduced ability to inhibit viral replication.
    Li CZ; Kato N; Chang JH; Muroyama R; Shao RX; Dharel N; Sermsathanasawadi R; Kawabe T; Omata M
    Liver Int; 2009 Oct; 29(9):1413-21. PubMed ID: 19515215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.
    Ragheb MM; Nemr NA; Kishk RM; Mandour MF; Abdou MM; Matsuura K; Watanabe T; Tanaka Y
    Liver Int; 2014 Jul; 34(6):890-5. PubMed ID: 24102823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy.
    Abe H; Hayes CN; Ochi H; Maekawa T; Tsuge M; Miki D; Mitsui F; Hiraga N; Imamura M; Takahashi S; Kubo M; Nakamura Y; Chayama K
    J Hepatol; 2011 Jun; 54(6):1094-101. PubMed ID: 21145800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytomegalovirus infection inhibits response of chronic hepatitis-C-virus-infected patients to interferon-based therapy.
    Bader el-Din NG; Abd el-Meguid M; Tabll AA; Anany MA; Esmat G; Zayed N; Helmy A; el-Zayady AR; Barakat A; el-Awady MK
    J Gastroenterol Hepatol; 2011 Jan; 26(1):55-62. PubMed ID: 21175794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients.
    Haj-Sheykholeslami A; Keshvari M; Sharafi H; Pouryasin A; Hemmati K; Mohammadzadehparjikolaei F
    World J Gastroenterol; 2015 Aug; 21(29):8935-42. PubMed ID: 26269684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of low viral load in haemodialysed patients with chronic hepatitis C virus infection.
    Sperl J; Frankova S; Senkerikova R; Neroldova M; Hejda V; Volfova M; Merta D; Viklicky O; Spicak J; Jirsa M
    World J Gastroenterol; 2015 May; 21(18):5496-504. PubMed ID: 25987772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients.
    Rallón NI; Naggie S; Benito JM; Medrano J; Restrepo C; Goldstein D; Shianna KV; Vispo E; Thompson A; McHutchison J; Soriano V
    AIDS; 2010 May; 24(8):F23-9. PubMed ID: 20389235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL28B polymorphisms predict the response to chronic hepatitis C virus infection treatment in a Mexican population.
    Martínez-Gómez LE; Chávez-Tapia NC; Burguete-García AI; Aguilar-Olivos N; Madrid-Marina V; Román-Bahena M; Orbe-Orihuela C; Misael U; Méndez-Sánchez N
    Ann Hepatol; 2012; 11(6):876-81. PubMed ID: 23109451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.